Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine

NCT01657526 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

BIOLOGICAL: GSK Biologicals' Non-Typeable H. influenzae (GSK2838500A)
BIOLOGICAL: GSK Biologicals' Non-Typeable H. influenzae (GSK2838501A)
BIOLOGICAL: Saline placebo

Sponsor

GlaxoSmithKline